Daniel Boone III
Member since: Jul '04
Portfolio Manager at
Calvert Social Investment Equity Fund

Latest Top Picks

A high quality, growth company. Good price. The leading medical technology company in the world.
Has a wonderful competitive advantage. Expects a growth of 13/15% over the next five years. A high quality, growth company. Good price.
Has a competitive advantage that can't be matched. Cut out overhead and sells equipment at the lowest price. Continuing to gain market share. Should grow 15/20% over the next five years.